Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gennex Laboratories is an Indian pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and therapeutic intermediates. Headquartered in Hyderabad, the company operates a robust manufacturing infrastructure that adheres to global regulatory standards, including USFDA and EU-GMP guidelines. Its core product portfolio features high-volume APIs such as Guaifenesin, Methocarbamol, and Phenylephrine Hydrochloride, serving major therapeutic segments like respiratory care and musculoskeletal health. Gennex operates as a key supplier and contract manufacturing partner for global pharmaceutical firms across North America, Europe, and Asia. The company is publicly traded on the Bombay Stock Exchange and continues to expand its chemical synthesis capabilities for complex generic molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gennex Laboratories.